GENERATE BIOLOGICS, INC. – Trademark Portfolio
Entity Type: 03
GENERATE BIOLOGICS, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GENERATE. The owner is based in CAMBRIDGE, MA.
55 CAMBRIDGE PARKWAY, SUITE 800E
CAMBRIDGE, MA 02142
Showing of trademarks Trademarks
Trademark Classifications
GENERATE BIOLOGICS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does GENERATE BIOLOGICS, INC. have?
GENERATE BIOLOGICS, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.
What trademark classes does GENERATE BIOLOGICS, INC. file in?
GENERATE BIOLOGICS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are GENERATE BIOLOGICS, INC.'s most well-known trademarks?
GENERATE BIOLOGICS, INC.'s registered trademark portfolio includes well-known marks such as GENERATE. These are among 1 currently registered trademark in the portfolio.
What is GENERATE BIOLOGICS, INC.'s trademark registration success rate?
GENERATE BIOLOGICS, INC. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.